Cogent Biosciences Inc. (COGT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
8.08
0.71 (9.63%)
At close: Jan 15, 2025, 1:56 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | -192.41M | -140.24M | -72.27M | -74.81M | -31.83M | -34.53M | -25.49M | -18.12M | -6.59M |
Depreciation & Amortization | 3.59M | 5.88M | 147.00K | 720.00K | 1.29M | 1.32M | 1.17M | 830.00K | 179.00K |
Stock-Based Compensation | 30.62M | 18.37M | 11.69M | 6.02M | 3.24M | 3.09M | 1.34M | 1.02M | 248.00K |
Other Working Capital | 6.63M | -1.61M | -731.00K | -1.31M | -16.63M | -3.90M | -3.88M | -2.86M | 23.25M |
Other Non-Cash Items | -6.87M | -3.39M | -343.00K | 45.03M | -131.00K | 23.00K | 7.00K | -56.00K | 248.00K |
Deferred Income Tax | n/a | n/a | n/a | -7.49M | n/a | -236.00K | 17.00K | 17.00K | -248.00K |
Change in Working Capital | 11.44M | 751.00K | 2.02M | -5.32M | -14.08M | -2.15M | -2.88M | -2.32M | 23.88M |
Operating Cash Flow | -153.62M | -118.64M | -58.76M | -35.85M | -41.51M | -32.49M | -25.84M | -18.64M | 17.72M |
Capital Expenditures | -2.80M | -6.86M | -1.72M | n/a | -33.00K | -549.00K | -912.00K | -3.31M | -1.99M |
Acquisitions | n/a | 117.86K | n/a | 8.42M | 204.00K | n/a | n/a | n/a | n/a |
Purchase of Investments | -348.80M | -177.85M | n/a | n/a | -204.00K | -47.68M | -6.50M | -55.17M | n/a |
Sales Maturities Of Investments | 253.78M | 60.00M | n/a | n/a | 22.99M | 37.70M | 21.00M | 28.00M | n/a |
Other Investing Acitivies | n/a | -117.86K | n/a | 8.42K | 204.00K | n/a | -75.00K | 50.00K | -1.25M |
Investing Cash Flow | -97.82M | -124.72M | -1.72M | 8.42M | 23.16M | -10.53M | 13.51M | -30.43M | -3.25M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.72M | 1.61M | -30.00K | 99.47M | 108.00K | -1.45M | -789.00K | -40.00K | 70.75M |
Financial Cash Flow | 163.54M | 163.56M | 37.98M | 232.20M | 108.00K | 70.35M | -729.00K | -40.00K | 70.75M |
Net Cash Flow | -87.91M | -79.80M | -22.51M | 204.77M | -18.25M | 27.33M | -13.05M | -49.11M | 85.22M |
Free Cash Flow | -156.42M | -125.50M | -60.48M | -35.85M | -41.55M | -33.04M | -26.75M | -21.95M | 15.72M |